11 Einträge gefunden

1. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma:a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

   1. Franklin, Cindy
   2. Mohr, Peter
   3. Bluhm, Leonie
   4. Meier, Friedegund
   5. Garzarolli, Marlene
   6. Weichenthal, Michael
   7. Kähler, Katharina

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

   1. Zaremba, Anne
   2. Mohr, Peter
   3. Gutzmer, Ralf
   4. Meier, Friedegund
   5. Pföhler, Claudia
   6. Weichenthal, Michael
   7. Terheyden, Patrick

   2023 - Forschungsinformationssystem des UKE
3. Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives

   1. Heppt, Markus V
   2. Gebhardt, Christoffer
   3. Hassel, Jessica C
   4. Alter, Mareike
   5. Gutzmer, Ralf
   6. Leiter, Ulrike
   7. Berking, Carola

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry

   1. Haist, Maximilian
   2. Stege, Henner
   3. Lang, Berenice Mareen
   4. Tsochataridou, Aikaterini
   5. Salzmann, Martin
   6. Mohr, Peter
   7. Schadendorf, Dirk

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Auswirkungen der COVID-19-Pandemie auf die Versorgung von Patienten mit malignem Melanom

   1. Welzel, Julia
   2. Augustin, Matthias
   3. Gutzmer, Ralf

   2022 - Forschungsinformationssystem des UKE
6. Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients

   1. DeTemple, Viola K
   2. Hassel, Jessica C
   3. Sachse, Michael M
   4. Grimmelmann, Imke
   5. Leiter, Ulrike
   6. Gebhardt, Christoffer
   7. Eckardt, Julia

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
7. First-line therapy-stratified survival in BRAF-mutant melanoma:a retrospective multicenter analysis

   1. Schilling, Bastian
   2. Martens, Alexander
   3. Geukes Foppen, Marnix H
   4. Gebhardt, Christoffer
   5. Hassel, Jessica C
   6. Rozeman, Elisa A
   7. Gesierich, Anja

   2019 - Forschungsinformationssystem des UKE
8. Fear of cancer progression in patients with stage IA malignant melanoma

   1. Wagner, Tobias
   2. Augustin, Matthias
   3. Blome, Christine
   4. Forschner, Andrea
   5. Garbe, Claus
   6. Gutzmer, Ralf
   7. Hauschild, Axel

   2018 - Forschungsinformationssystem des UKE
9. The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

   1. Kähler, Katharina
   2. Blome, Christine
   3. Forschner, A
   4. Gutzmer, Ralf
   5. Hauschild, Axel
   6. Heinzerling, L
   7. Livingstone, Elisabeth

   2018 - Forschungsinformationssystem des UKE
10. Willingness to pay for a cure of low-risk melanoma patients in Germany

    1. Augustin, Matthias
    2. Blome, Christine
    3. Forschner, Andrea
    4. Gutzmer, Ralf
    5. Hauschild, Axel
    6. Heinzerling, Lucie
    7. Livingstone, Elisabeth

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
11. Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy

    1. Kaehler, Katharina C
    2. Blome, Christine
    3. Forschner, Andrea
    4. Gutzmer, Ralf
    5. Haalck, Thomas
    6. Heinzerling, Lucie
    7. Kornek, Thomas

    2016 - Forschungsinformationssystem des UKE - frei zugänglich